Thyrocare to triple authorized capital, proposes 2:1 bonus share issue

Thyrocare Technologies Limited has announced a postal ballot to seek shareholder approval for a substantial increase in its authorized share capital from INR 1,00,00,00,000 to INR 3,00,00,00,000. This expansion aims to accommodate a proposed bonus share issue and future requirements. Shareholders will also vote on altering the company’s Articles of Association to reflect these changes and incorporate specific provisions for the capitalization of profits.

The company plans to issue bonus equity shares in a 2:1 ratio (two new bonus shares for every one existing share) to eligible members as of the record date. This will be done by capitalizing a sum not exceeding INR 106.11 Crore. These bonus shares will be fully paid-up, with a face value of INR 10 each, and will be allotted in dematerialized form.

The e-voting period for these resolutions will run from Saturday, October 18, 2025, at 9:00 A.M. (IST) to Sunday, November 16, 2025, at 5:00 P.M. (IST). Results are expected to be declared on or before Tuesday, November 18, 2025. The board of directors recommends all resolutions, deeming them in the interest of the company and its investors.